Pages that link to "Q53655364"
Jump to navigation
Jump to search
The following pages link to Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. (Q53655364):
Displaying 30 items.
- Different sources of autologous mononuclear cells and stem cells for critical lower limb ischaemia (Q24198835) (← links)
- Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections (Q24200397) (← links)
- Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections (Q24240046) (← links)
- The multi-differentiation potential of peripheral blood mononuclear cells (Q26852323) (← links)
- Autologous bone marrow cell therapy for peripheral arterial disease (Q27026719) (← links)
- Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study (Q30409726) (← links)
- A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease (Q33901995) (← links)
- Elevated monocytes in patients with critical limb ischemia diminish after bypass surgery (Q33956883) (← links)
- Toward a mouse model of hind limb ischemia to test therapeutic angiogenesis (Q34353144) (← links)
- Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. (Q35629442) (← links)
- Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. (Q35848867) (← links)
- Fucoidan Stimulates Monocyte Migration via ERK/p38 Signaling Pathways and MMP9 Secretion. (Q35890701) (← links)
- Peripheral blood as a source of stem cells for regenerative medicine. (Q36407227) (← links)
- Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease (Q36655337) (← links)
- Early and Long-term Effects of the Autologous Peripheral Stem Cell Implantation for Critical Limb Ischemia (Q36734655) (← links)
- Thromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategy (Q36757085) (← links)
- Modulating the vascular response to limb ischemia: angiogenic and cell therapies. (Q36908997) (← links)
- Emerging hurdles in stem cell therapy for peripheral vascular disease (Q37246834) (← links)
- Cell therapy in peripheral arterial disease (Q37279639) (← links)
- Cell therapy of peripheral arterial disease: from experimental findings to clinical trials (Q37338896) (← links)
- Autologous peripheral blood CD133 cell implantation for limb salvage in patients with critical limb ischemia (Q37633958) (← links)
- Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review (Q38001506) (← links)
- Cell therapy for cardiovascular diseases (Q38095938) (← links)
- Regenerative capacity of autologous stem cell transplantation in elderly: a report of biomedical outcomes (Q39154453) (← links)
- Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans (Q39830451) (← links)
- Stem cell therapy in patients with thromboangiitis obliterans: assessment of the long-term clinical outcome and analysis of the prognostic factors (Q42158202) (← links)
- Short- to Mid-Term Results Using Autologous Bone-Marrow Mononuclear Cell Implantation Therapy as a Limb Salvage Procedure in Patients With Severe Peripheral Arterial Disease (Q53420512) (← links)
- Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients (Q57166884) (← links)
- Long-term follow-up of patients with Buerger's disease after autologous stem cell therapy (Q64228120) (← links)
- Intracerebroventricular administration of bone marrow-derived cells attenuates angiotensin II-initiated neurogenic hypertension in rats (Q91013940) (← links)